Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

As devotees take a holy dip at Mahakumbh, the Yogi government has taken significant steps to safeguard their health.

The global continuous renal replacement therapy market is set for significant expansion, with projections indicating a surge ...

The Philippine Health Insurance Corporation (PhilHealth) has substantially enhanced its Z Benefit Package for Peritoneal Dialysis, this time with separate packages for adult and pediatric patients, ...

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

Its growth is driven by the rising prevalence of kidney and urological disorders. The global market for nephrology and urology devices is projected to reach $39.3b by 2030, at a compound annual growth ...

Some clinical trials have validated a new perspective on continuous renal replacement therapy (CRRT) in combination with oXiris haemofilter to more effectively enhance endotoxins clearance and ...

The trial is assessing the efficacy and safety of the company's selective cytopheretic device (SCD) in conjunction with continuous renal replacement therapy (CRRT). The trial aims to enrol 200 adult ...

IN A major win for dialysis patients, the Philippine Health Insurance Corp. (PhilHealth) has significantly enhanced its Z ...

VolitionRx (VNRX) announced the results of a large-scale study which shows that its Nu.Q NETs H3.1 biomarker is an independent predictor of ...

Researchers assessed whether early albumin use among patients with septic shock and kidney impairment upon hospital admission reduced in-hospital mortality or the need for renal replacement ...